Clinical Trial Update: Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon

View source ↗

Summary

A clinical trial update indicates enrollment by invitation for a study of Acoltremon to relieve moderate-to-severe dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Acoltremon

Snippet

Sponsor: Colvard Kandavel Eye Center | Conditions: Dry Eye Disease (DED) | Status: ENROLLING_BY_INVITATION